Search clinical trials for: mild to moderate Hypertension

Total 471310 results

Glaukos Corporation

Recruiting

Glaukos® iStent Infinite Trabecular Micro-Bypass System in Subjects With Mild to Moderate Primary Open-angle Glaucoma

Glaucoma

United States
Diablo Eye Associates
Alcon Research

Recruiting

Combined Phacoemulsification With iStent Inject W Versus Hydrus for Mild to Moderate Open Angle Glaucoma

Open Angle Glaucoma

United States
Nova Eye, Inc.
Nova Eye Medical GmbH

Recruiting

Cataract Surgery in Conjunction With Ab-interno Canaloplasty Compared to Cataract Surgery Only in Patients With Mild to Moderate Primary Open-Angle Glaucoma (CATALYST)

Primary Open Angle Glaucoma

Germany
University of Central Lancashire
University of Hertfordshire

Not yet recruiting

Effects of Peppermint Oil in Mild-moderate Hypertension. A Pilot Feasibility Study.

Hypertension | Cardiometabolic Syndrome
University of California, Irvine

Recruiting

Acupuncture Therapy and Hypertension

Mild to Moderate Hypertension

United States
Celltrion

Not yet recruiting

A Phase 3 Study to Evaluate and Compare the Efficacy and Safety of AZM and AML Combined and Alone in Mild-to-moderate Essential Hypertensive Subjects

Essential Hypertension
Shanghai Pharmaceuticals Holding Co., Ltd

Recruiting

Study to Evaluate the Efficacy and Safety of SPH3127 In Patients With Mild-moderate Essential Hypertension

Essential Hypertension

China
Shenzhen People's Hospital

Recruiting

s086 Tablets in the Treatment of Mild to Moderate Essential Hypertension

Essential Hypertension

China
Syneos Health

Recruiting

First-in-Human Study of VB0004 in Healthy Subjects and to Patients With Mild to Moderate Hypertension With Low Cardiovascular Risk

Hypertension

Australia
University of California, Irvine

Recruiting

Effect of Electro-Acupuncture on Blood Pressure

Hypertension

United States
Alnylam Pharmaceuticals

Active, not recruiting

A Study to Evaluate Efficacy and Safety of ALN-AGT01 in Patients With Mild To-Moderate Hypertension (KARDIA-1) (KARDIA-1)

Hypertension

United States, Canada, United Kingdom, Puerto Rico, Ukraine
PolyActiva Pty Ltd

Active, not recruiting

Open Label, Sequential-dose Study of PA5108 Latanoprost FA SR Ocular Implant for Mild-moderate Glaucoma

Open Angle Glaucoma

Australia, New Zealand
Pfizer

Terminated

A Study to Measure the Amount of Study Medicine in Blood in Adult Participants With COVID-19 and Severe Kidney Disease

COVID-19

United States
Bayer

Completed

A Study in Male and Female Participants (After Menopause) With Mild to Moderate High Blood Pressure to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body and How it Moves Into, Through and Out of the Body After Taking Single and Multiple Doses

Hypertension | Chronic Kidney Disease

Germany, Bulgaria
Riphah International University

Completed

Comparative Effects of Mild and Moderate Aerobic Exercises on BP, VO2 and HR in Hypertensive Patients

Hypertension

Pakistan
Shanghai Pharmaceuticals Holding Co., Ltd

Completed

Study on Human Mass Balance of SPH3127 Tablets

Primary Mild and Moderate Hypertension

China
Sanofi

Completed

Comparison of Pharmacodynamic Effects of Sotagliflozin and Empagliflozin in T2DM Patients With Mild to Moderate Hypertension

Diabetes Mellitus

Germany
Vigonvita Life Sciences
Shanghai Institute of Materia Medica, Chinese Academy of Sciences

Completed

Study of the Pharmacokinetics and Safety of TPN171H Tablets in Subjects With Mild ,Moderate Hepatic Insufficiency and Normal Liver Function

Erectile Dysfunction | Pulmonary Arterial Hypertension

China
Organon and Co

Completed

Evaluate the Safety and Anti-Hypertensive Efficacy of Hyzaar(R) In Patients With Mild To Moderate Essential Hypertension (0954A-323)

Hypertension
Shanghai Pharmaceuticals Holding Co., Ltd
R&G Pharma Studies Co.,Ltd.

Completed

Safety and Efficacy of SPH3127 on Treating Mild-moderate Essential Hypertension Patients

Hypertension,Essential

China
Pfizer

Completed

A Dose Finding Study Of PF-00489791 In Patients With Mild To Moderate High Blood Pressure

Hypertension

United States
University of Aarhus
Herning Hospital; Randers Regional Hospital

Completed

Effect of RIC on BP and Inflammatory Response in Women With Pre-eclampsia

Gestational Hypertension | Pre-Eclampsia; Mild

Denmark
Novartis

Completed

Pharmacokinetic and Pharmacodynamic Profiles of Aliskiren in Japanese Patients With Mild to Moderate Essential Hypertension

Hypertension

Japan
Novartis Pharmaceuticals

Completed

Effect of Light Meal on Pharmacokinetic and Pharmacodynamics of Aliskiren in Patients With Mild to Moderate Hypertension

Hypertension

India
Novartis Pharmaceuticals

Terminated

LFF269 Compared to Placebo After Treatment in Subjects With Essential Hypertension

Hypertension

United States
Novartis

Completed

Efficacy and Tolerability of an Aliskiren-based Treatment Algorithm in Patients With Mild to Moderate Hypertension

Essential Hypertension ( Mild to Moderate)

Romania, Slovakia, Hungary, France
GE Healthcare
ABX CRO; H2O Clinical LLC; TransPerfect; Advanced Clinical, LLC; TFS; AG Mednet Inc.; ICON CEAC and other collaborators

Terminated

International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device (ADMIRE-ICD)

Heart Failure

United States, Spain, Canada, France, Netherlands, Poland, Czechia, Italy, Germany, Hungary
Peking University First Hospital
Bayer

Unknown

Effect of Nifedipine GITS in Patients With Mild-to-moderate Primary Hypertension

Hypertension

China
Pfizer

Completed

Olmesartan Alone or in Combination With Hydrochlorothiazide in Subjects With Mild to Moderate Essential Hypertension (OSCAR)

Essential Hypertension

Colombia, Singapore, Taiwan, Thailand, Ecuador, Indonesia, Philippines, Hong Kong, Malaysia, Turkey
ZS Pharma, Inc.

Completed

Safety & Efficacy of Zirconium Silicate in Mild to Moderate Hyperkalemia

Hyperkalemia

United States, Australia
Lee's Pharmaceutical Limited

Completed

Azilsartan in Chinese Patients With Mild and Moderate Hypertension

Hypertension

China
Boryung Pharmaceutical Co., Ltd
Chonnam National University Hospital; Seoul National University Hospital; Kyungpook... and other collaborators

Completed

A Therapeutic Exploratory Clinical Study to Evaluate the Antihypertensive Efficacy of Fimasartan (BR-A-657•K) During 24 Hours in Patients With Mild to Moderate Essential Hypertension

Essential Hypertension
Novartis

Completed

A Study in Chinese Mild to Moderate Hypertensive Patients Comparing the Efficacy of Co-Diovan With Diovan.

Hypertension

United States
Takeda

Withdrawn

An Efficacy and Safety Study Evaluating the Fixed-Dose Combination of Candesartan Plus Amlodipine in Participants With Mild/Moderate Essential Hypertension

Hypertension

China
Novartis

Completed

VALID: Study to Compare the Reduction of Predialysis Systolic Blood Pressure With Valsartan Compared to Irbesartan in Patients With Mild to Moderate Hypertension on Long-term Hemodialysis

Hypertension

Switzerland, Germany
Bayer

Completed

Study of Nifedipine GITS and Candesartan Combination Compared to Monotherapy in Patients With Essential Hypertension (DISTINCT)

Hypertension, Essential

Spain, Argentina, United States, Canada, Korea, Republic of, Italy, Russian Federation, South Africa, Ukraine, Belgium, Brazil, Lithuania, United Kingdom
Novartis

Completed

Study Comparing SPP100 (Aliskiren) 150mg to Placebo and to Losartan 50mg in Patients With Mild to Moderate Essential Hypertension

Hypertension

Japan
Novartis

Completed

Efficacy and Safety of Aliskiren and Atenolol in Adults (>18) With Mild to Moderate Hypertension

Hypertension

Germany, Switzerland
BTG International Inc.
Encorium

Terminated

Safety and Efficacy Study of Angiotensin Therapeutic Vaccine in Subjects With Mild to Moderate Hypertension

Hypertension | Cardiovascular Disease

United Kingdom
Boryung Pharmaceutical Co., Ltd
Asan Medical Center; Ulsan University Hospital; Korea University Anam Hospital; Dong-A University and other collaborators

Completed

A Multicenter, Phase 3 Study to Evaluate the Antihypertensive Efficacy and Safety of Fimasartan(BR-A-657∙K) 30mg Compared to Placebo in Patients With Mild to Moderate Essential Hypertension (fimasartan)

Hypertension

Korea, Republic of
Boryung Pharmaceutical Co., Ltd
Seoul National University Hospital

Completed

A Clinical Trial to Evaluate Efficacy, Tolerability, and Pharmacokinetic-Pharmacodynamic Relationship of Fimasartan/Hydrochlorothiazide

Hypertension

Korea, Republic of
Sanofi

Completed

AVE7688 in Patients With Mild to Moderate Blood Pressure (RAVEL-1)

Hypertension

United States, Canada, Brazil, Poland, Russian Federation, Germany, Italy, Netherlands, Portugal, Spain, Turkey, Malaysia, Singapore, Taiwan, Mexico, Argentina, Korea, Republic of, Chile, Hong Kong, South Africa, Greece
Ono Pharmaceutical Co. Ltd

Completed

A 28 Day Study of ONO-9054 Ophthalmic Solution in Subjects With Ocular Hypertension (OHT) or Open-angle Glaucoma (OAG)

Ocular Hypertension | Open Angle-glaucoma

United States
Institute of Liver and Biliary Sciences, India

Completed

Role of Hypertonic Saline Versus Mannitol in the Management of Raised Intracranial Pressure in Patients With ALF

Acute Liver Failure

India
Novartis Pharmaceuticals

Completed

An 8-week Study to Evaluate the Dose Response of AHU377 in Combination With Valsartan 320 mg in Patients With Mild-to-moderate Systolic Hypertension

Systolic Hypertension

United States, Spain, Hungary, Korea, Republic of, Argentina, India, Slovakia, Canada, Romania
KGK Science Inc.
Marealis AS

Completed

Effect and Safety of Marealis RPC (Refined Peptide Concentrate) in Mild or Moderate Hypertensive Subjects

Prehypertension

Canada, United States, Czech Republic, Germany
Novartis Pharmaceuticals

Completed

Evaluation of Drug-drug Interaction Between LCZ696 and Sildenafil in Subjects With Mild to Moderate Hypertension

Mild to Moderate Hypertension

Germany
Monash University
Schering-Plough

Withdrawn

Angiotensin Receptor Blocker Combined With Calcium Antagonist Evaluation of Safety and Lowering of Systolic Blood Pressure Study (ACCESS)

Hypertension

Australia
Ferrer Internacional S.A.

Completed

Hypertension Study: Multinational Torasemide Trial in Mild to Moderate Hypertension.

Hypertension
Shanghai Shyndec Pharmaceutical Co., Ltd.

Completed

Efficacy Study of Nifedipine Controlled-Release Tablets (Xin Ran) to Treat Mild to Moderate Essential Hypertension

Essential Hypertension

China

3

Subscribe